BACKGROUND: Dimethyl fumarate (DMF) is a disease-modifying therapy used for patients with relapsing-remitting multiple sclerosis (RRMS). B cells are important contributors to the pathogenesis of RRMS, where they regulate the inflammatory immune responses and participate in development of lesions in the central nervous system (CNS). The impact of DMF on B cell subpopulations remains incompletely understood. OBJECTIVES: In this study, we evaluated the effects of DMF on B cell subpopulations and their effector functions. METHODS: Blood from 21 DMF-treated and 18 untreated patients with RRMS was analyzed by flow cytometry. RESULTS: We found that DMF reduces the frequency of circulating antigen-experienced B cells, a reduction likely related to a reduced frequency of follicular helper T (TFH) cells and an increased frequency of follicular regulatory T (TFR) cells. Studying the impact of monomethyl fumarate (MMF), the primary metabolite of DMF, on B cell effector function in vitro showed that MMF increased the frequency of transforming growth factor (TGF)-β-producing B cells and decreased the frequency of B cells secreting lymphotoxin (LT)-α, tumor necrosis factor (TNF)-α, interleukin (IL)-6, and to a lesser extent IL-10. CONCLUSION: In summary, these data suggest an anti-inflammatory role of DMF and its metabolite MMF on the B cell compartment.
BACKGROUND:Dimethyl fumarate (DMF) is a disease-modifying therapy used for patients with relapsing-remitting multiple sclerosis (RRMS). B cells are important contributors to the pathogenesis of RRMS, where they regulate the inflammatory immune responses and participate in development of lesions in the central nervous system (CNS). The impact of DMF on B cell subpopulations remains incompletely understood. OBJECTIVES: In this study, we evaluated the effects of DMF on B cell subpopulations and their effector functions. METHODS: Blood from 21 DMF-treated and 18 untreated patients with RRMS was analyzed by flow cytometry. RESULTS: We found that DMF reduces the frequency of circulating antigen-experienced B cells, a reduction likely related to a reduced frequency of follicular helper T (TFH) cells and an increased frequency of follicular regulatory T (TFR) cells. Studying the impact of monomethyl fumarate (MMF), the primary metabolite of DMF, on B cell effector function in vitro showed that MMF increased the frequency of transforming growth factor (TGF)-β-producing B cells and decreased the frequency of B cells secreting lymphotoxin (LT)-α, tumor necrosis factor (TNF)-α, interleukin (IL)-6, and to a lesser extent IL-10. CONCLUSION: In summary, these data suggest an anti-inflammatory role of DMF and its metabolite MMF on the B cell compartment.
Entities:
Keywords:
B cells; Multiple sclerosis; cytokines; dimethyl fumarate; follicular helper T cells
Authors: Martin Diebold; Edoardo Galli; Andreas Kopf; Nicholas S R Sanderson; Ilaria Callegari; Pascal Benkert; Nicolás Gonzalo Núñez; Florian Ingelfinger; Stefan Herms; Sven Cichon; Ludwig Kappos; Jens Kuhle; Burkhard Becher; Manfred Claassen; Tobias Derfuss Journal: Proc Natl Acad Sci U S A Date: 2022-07-26 Impact factor: 12.779
Authors: Natsuki Eguchi; Arvin John Toribio; Michael Alexander; Ivana Xu; David Lee Whaley; Luis F Hernandez; Donald Dafoe; Hirohito Ichii Journal: Biomedicines Date: 2022-02-17
Authors: Paulus S Rommer; Ron Milo; May H Han; Sammita Satyanarayan; Johann Sellner; Larissa Hauer; Zsolt Illes; Clemens Warnke; Sarah Laurent; Martin S Weber; Yinan Zhang; Olaf Stuve Journal: Front Immunol Date: 2019-07-11 Impact factor: 7.561
Authors: María José Mansilla; Juan Navarro-Barriuso; Silvia Presas-Rodríguez; Aina Teniente-Serra; Bibiana Quirant-Sánchez; Cristina Ramo-Tello; Eva María Martínez-Cáceres Journal: CNS Neurosci Ther Date: 2019-05-07 Impact factor: 5.243